.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Medtronic
Baxter
Fuji
Johnson and Johnson
QuintilesIMS
Dow
AstraZeneca
Cerilliant
UBS

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006383

« Back to Dashboard
NDA 006383 describes METHADONE HYDROCHLORIDE, which is a drug marketed by Aurolife Pharma Llc, Vistapharm, Roxane, Mallinckrodt, Mylan Institutional, The Pharmanetwork, Sandoz, Mallinckrodt Inc, West-ward Pharms Int, and Epic Pharma Llc, and is included in nineteen NDAs. It is available from eighteen suppliers. Additional details are available on the METHADONE HYDROCHLORIDE profile page.

The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.

Summary for NDA: 006383

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 006383

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 006383

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHADONE HYDROCHLORIDE
methadone hydrochloride
POWDER;FOR RX COMPOUNDING 006383 NDA Mallinckrodt, Inc. 0406-1510 0406-1510-56 50 g in 1 BOTTLE, GLASS (0406-1510-56)
METHADONE HYDROCHLORIDE
methadone hydrochloride
POWDER;FOR RX COMPOUNDING 006383 NDA Mallinckrodt, Inc. 0406-1510 0406-1510-57 100 g in 1 BOTTLE, GLASS (0406-1510-57)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;FOR RX COMPOUNDINGStrength50GM/BOT
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:POWDER;FOR RX COMPOUNDINGStrength100GM/BOT
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:POWDER;FOR RX COMPOUNDINGStrength500GM/BOT
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cipla
Harvard Business School
UBS
US Army
Daiichi Sankyo
Healthtrust
Chubb
Julphar
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot